IN2014MN01551A - - Google Patents
Info
- Publication number
- IN2014MN01551A IN2014MN01551A IN1551MUN2014A IN2014MN01551A IN 2014MN01551 A IN2014MN01551 A IN 2014MN01551A IN 1551MUN2014 A IN1551MUN2014 A IN 1551MUN2014A IN 2014MN01551 A IN2014MN01551 A IN 2014MN01551A
- Authority
- IN
- India
- Prior art keywords
- geranylgeranylacetone
- composition
- cells
- mixture
- various retina
- Prior art date
Links
- DJAHKBBSJCDSOZ-AJLBTXRUSA-N (5z,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;(5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C/CCC(C)=O.CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O DJAHKBBSJCDSOZ-AJLBTXRUSA-N 0.000 abstract 6
- 229950006156 teprenone Drugs 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 5
- 210000001525 retina Anatomy 0.000 abstract 2
- 230000007850 degeneration Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012040779 | 2012-02-27 | ||
| PCT/JP2013/054779 WO2013129317A1 (ja) | 2012-02-27 | 2013-02-25 | ゲラニルゲラニルアセトンを含む眼科用組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01551A true IN2014MN01551A (enrdf_load_stackoverflow) | 2015-05-08 |
Family
ID=49082514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1551MUN2014 IN2014MN01551A (enrdf_load_stackoverflow) | 2012-02-27 | 2013-02-25 |
Country Status (7)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI564006B (zh) * | 2012-02-27 | 2017-01-01 | 樂敦製藥股份有限公司 | 包含香葉基香葉基丙酮之眼科用組成物 |
| WO2014129466A1 (ja) * | 2013-02-19 | 2014-08-28 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
| JP5483513B1 (ja) * | 2013-02-19 | 2014-05-07 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
| WO2015029925A1 (ja) * | 2013-08-26 | 2015-03-05 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療剤 |
| CN110893180A (zh) * | 2018-09-12 | 2020-03-20 | 厦门信力康生物技术有限公司 | 替普瑞酮及其衍生物作为制备治疗毒品成瘾和防止复吸药物的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06192073A (ja) * | 1992-12-24 | 1994-07-12 | Eisai Co Ltd | 細胞分化誘導剤 |
| JPH08133967A (ja) * | 1994-11-02 | 1996-05-28 | Eisai Co Ltd | ドライアイ治療剤 |
| JP2000319170A (ja) * | 1999-03-05 | 2000-11-21 | Eisai Co Ltd | テプレノン含有点眼剤 |
| US20050009772A1 (en) * | 2003-05-06 | 2005-01-13 | The Regents Of The University Of California | Methods and compositions for the treatment of glaucoma and other retinal diseases |
| JP5027425B2 (ja) * | 2006-02-17 | 2012-09-19 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ゲラニルゲラニルアセトンを有効成分として含むチャンネル病治療剤 |
| CN1903188B (zh) * | 2006-08-03 | 2011-07-27 | 首都医科大学附属北京同仁医院 | 替普瑞酮在制备预防和/或治疗青光眼所致外侧膝状体神经元损害的药物中的应用 |
| CN103052619A (zh) * | 2010-09-01 | 2013-04-17 | 科约特制药公司 | 治疗神经退行性疾病的方法 |
| CN102627539B (zh) * | 2011-10-19 | 2014-04-16 | 利安隆博华（天津）医药化学有限公司 | 一种生产全反式替普瑞酮的方法 |
| TWI564006B (zh) * | 2012-02-27 | 2017-01-01 | 樂敦製藥股份有限公司 | 包含香葉基香葉基丙酮之眼科用組成物 |
-
2013
- 2013-02-25 TW TW102106509A patent/TWI564006B/zh not_active IP Right Cessation
- 2013-02-25 IN IN1551MUN2014 patent/IN2014MN01551A/en unknown
- 2013-02-25 US US13/775,524 patent/US20130303624A1/en not_active Abandoned
- 2013-02-25 JP JP2013510416A patent/JP5358748B1/ja not_active Expired - Fee Related
- 2013-02-25 WO PCT/JP2013/054779 patent/WO2013129317A1/ja active Application Filing
- 2013-02-25 HK HK15100637.2A patent/HK1200112A1/xx unknown
- 2013-02-25 CN CN201380011324.9A patent/CN104136018A/zh active Pending
- 2013-07-12 JP JP2013146978A patent/JP2013213050A/ja active Pending
-
2014
- 2014-08-15 US US14/460,564 patent/US20140350119A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5358748B1 (ja) | 2013-12-04 |
| HK1200112A1 (en) | 2015-07-31 |
| CN104136018A (zh) | 2014-11-05 |
| WO2013129317A1 (ja) | 2013-09-06 |
| TW201340963A (zh) | 2013-10-16 |
| JPWO2013129317A1 (ja) | 2015-07-30 |
| US20130303624A1 (en) | 2013-11-14 |
| TWI564006B (zh) | 2017-01-01 |
| US20140350119A1 (en) | 2014-11-27 |
| JP2013213050A (ja) | 2013-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20150223A1 (es) | Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos | |
| IN2015DN00544A (enrdf_load_stackoverflow) | ||
| CA2900335C (en) | Synthetic analogs of epipolythiodioxopiperazines and uses thereof | |
| MX2013004061A (es) | Analogos de ciclosporina. | |
| PH12013502240B1 (en) | Novel compounds as modulators of protein kinase | |
| CA2840307C (en) | Progenitor cells of mesodermal lineage | |
| IN2014DN10386A (enrdf_load_stackoverflow) | ||
| HK1213888A1 (zh) | 治療化合物和組合物以及其作為pkm2調節劑的用途 | |
| IL234101B (en) | Preparations containing acamprosate and baclofen for use in the treatment of Parkinson's disease | |
| IN2014MN01551A (enrdf_load_stackoverflow) | ||
| ZA201502979B (en) | A porous silica material for use as a pharmaceutical or dietary active ingredient | |
| EA201491690A1 (ru) | Частицы пористого углерода для применения при лечении или профилактике заболевания печени | |
| MX356052B (es) | Terapias sinergicas de cannabidiol con hipotermia para neuroproteccion. | |
| IN2014MN01552A (enrdf_load_stackoverflow) | ||
| MX2013004062A (es) | Analogos de ciclosporina. | |
| IN2014MN01553A (enrdf_load_stackoverflow) | ||
| IN2014DN07326A (enrdf_load_stackoverflow) | ||
| MX355668B (es) | Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. | |
| NZ713129A (en) | Oxprenolol compositions for treating cancer | |
| MX362854B (es) | Siarn y su uso en los metodos y composiciones para el tratamiento y/o prevencion de enfermedades de los ojos. | |
| SA521420975B1 (ar) | صيغ ذات تركيبة نانوية لتوصيل سيليبينين وعناصر نشطة أخرى لعلاج أمراض العين | |
| PH12014500344A1 (en) | Composition for use in the promotion of magnesium absorption and/or magnesium retention | |
| WO2015024577A3 (fr) | Composition a base de safranal | |
| GB201114230D0 (en) | Addition copolymers and their use | |
| PH12015501109A1 (en) | Novel compounds as diacylglycerol acyltransferase inhibitors |